AMRN

#3389
Amarin Corp Plc
13.9500 USD
-0.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
13.4000
13.9900
Year Range
13.4000
17.0000
Daily Change
-0.07%
Monthly Change
-3.46%
6 month change
-10.35%
Year Change
-10.35%
Previous Close
13.9600
Open
13.4000
Low
13.4000
High
13.9900
Volume
49
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 290.2152 M
  • Employee 80
  • Founded 1989
  • CEO N/A
  • Website www.amarincorp.com
  • Headquarter United Kingdom
  • FIGI BBG000BPYG99
  • Industry Drug Manufacturers—General
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-155.06
Price to sales ratio
27.11

Amarin Corporation plc - American Depositary Shares, each repre

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza.

News